Chronic severe hepatitis (CSH) made up 83.9% of total cases of SH.
慢性重型肝炎病例在重型肝炎中占83.9%。
ETV has good security in the treatment for chronic severe hepatitis B.
ETV治疗慢性重型乙型肝炎有较好的安全性。
Chronic severe hepatitis has direct influence on the erythrocyte sedimentation rate.
慢性重型肝炎对红细胞沉降率有直接的影响。
Objective: To discuss the treatment of viral chronic severe hepatitis with hyponatremia.
目的：探讨慢性重型病毒性肝炎患者低钠血症的治疗。
Methods 36 patients with chronic severe hepatitis B were randomly divided into 2 groups.
方法36例慢性重型乙型肝炎患者随机分为2组。
Methods: 61 cases of chronic severe hepatitis patients were randomly divided into two groups.
方法：将61例慢性乙型重型肝炎患者随机分为治疗组和对照组。
Objective to probe into the level of erythrocyte sedimentation rate with chronic severe hepatitis.
目的：探讨慢性重型肝炎红细胞沉降率的水平。
The scores of MELD in the chronic severe hepatitis are correlated to the patient's condition and prognosis.
慢性重型肝炎患者MELD评分分值与病情严重程度和预后有关。
Objective: To investigate the effects of colon herbal dialysis in patients with chronic severe hepatitis b.
目的：观察中药结肠透析疗法对慢性重型肝炎的临床效果。
Conclusion TLR2 and TLR4 may have a role in the pathogenesis of chronic hepatitis B and chronic severe hepatitis B.
结论TLR2和TLR4可能与慢性乙型肝炎及慢性重型乙型肝炎的发病有关。
Methods: 70 patients with chronic severe hepatitis B were divided at random into therapeutic group and control group.
方法：70例慢性重型肝炎患者，随机分成治疗组及对照组。
To observe the clinical effect and adverse effect of foscarnet sodium in treating patients with chronic severe hepatitis B.
目的探讨膦甲酸钠治疗慢性重型乙型肝炎的疗效及其不良反应。
Results: The6patients were diagnosised with chronic severe hepatitis, 2patients were diagnosised with acute severe hepatitis.
结果：6例患者为慢性重型肝炎，2例患者为急性重型肝炎。
Methods The erythrocyte sedimentation rate was detected in 45 cases of chronic severe hepatitis and 40 normal people as control.
对45例慢性重型肝炎患者进行红细胞沉降率的检测，并与40例健康对照组进行比较。
Conclusions The effects of colon herbal dialysis combining with supportive treatment on chronic severe hepatitis are significant.
结论中药结肠透析配合综合支持治疗慢性重型肝炎疗效显著。
Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver.
目的应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝，进一步评价其安全性和疗效。
Conclusion it can be concluded that Entecavir has good therapeutic efficiency and safety in the treatment of chronic severe hepatitis b.
结论恩替卡韦治疗慢性重型乙型肝炎具有较好的疗效和安全性。
Objective To evaluate the treatment of plasma exchange(PE) in patients with chronic severe hepatitis based on prothrombin activity(PTA).
目的探讨根据凝血酶原活动度（PTA）预测重型肝炎高胆红素血症行血浆置换的临床疗效。
AIM: to observe the efficacy of treating chronic severe hepatitis with hepatocyte growth factor (HGF) combining with conventional therapy.
目的：观察肝细胞生长因子(HGF)合并常用综合疗法治疗慢性重症肝炎的疗效。
Objective To discuss the clinical effect of artificial liver support system in treating patients with chronic severe hepatitis and the safety.
目的探讨人工肝支持治疗对慢性重型肝炎患者的临床效果及安全性。
Serum collagen iv level was elevated in the groups of chronic persistent hepatitis, chronic active hepatitis, and chronic severe hepatitis o...
血清iv型胶原的测定对慢性肝病纤维化严重程度和预后的判断有重要临床意义。
Objective to investigate the clinical and laboratory indexes affecting prognosis of chronic severe hepatitis and construct the prognostic model.
目的：探讨影响慢性重型肝炎预后的临床及化验室指标，并建立预后模型。
ObjectiveTo study the significance of AICD(activation-induced cell death) in the pathogenesis of chronic hepatitis B and chronic severe hepatitis B.
目的研究激活诱导细胞死亡（AICD）现象在乙型肝炎慢性化和重型化机制中的意义。
The plasma exchange's efficacy for chronic severe hepatitis patients with underlying liver cirrhosis were lower than those with chronic hepatitis(P<0.01).
在肝硬化基础上发生的重型肝炎患者血浆置换的疗效低于在慢性肝炎基础上发生的重型肝炎（P<0.01）；
Conclusion Ursofalk combined with artificial liver treatment and conventional therapy is safe and more effective in treatment of chronic severe hepatitis.
结论优思弗联合人工肝治疗慢性重型肝炎是安全和有效的。
Objective To investigate changes in intestinal microflora in patients with chronic severe hepatitis (CSH), and their role in this life-threatening disease.
目的研究慢性重型肝炎患者肠道菌群的变化及其在这种重危疾病的发病过程中的作用。
Conclusion Intestinal flora in patients with chronic severe hepatitis were severely disturbed and gut mircobiological colonization resistance was impaired.
结论慢性重型肝炎患者肠道菌群严重失调，肠道定植抗力严重受损。
AIM: To observe the therapeutic effect of hepatocyte growth promoting factor (PHGF) combined with transmetil in treatment of chronic severe hepatitis (CSF).
目的：观察促肝细胞生长素联合腺苷蛋氨酸治疗慢重肝的疗效。
Objective To study the influence of duodenal drainage on the treatment of biliary tract infection in chronic severe hepatitis, and the occurrence of the bacterial species.
目的了解十二指肠引流对慢性重型肝炎胆道感染治疗的影响及慢性重型肝炎胆道感染的细菌分布。
Objective To study the influence of duodenal drainage on the treatment of biliary tract infection in chronic severe hepatitis, and the occurrence of the bacterial species.
目的了解十二指肠引流对慢性重型肝炎胆道感染治疗的影响及慢性重型肝炎胆道感染的细菌分布。
应用推荐